Home
FAQ
Membership
Login
Register
Contact us
Image gallery for:
Uniqure wins first fda rmat in huntington’s disease after strong phase i ii data
Advertisement
J&J Wins Bi-Weekly Dosing Approval from FDA for Tecvayli in Multiple Myeloma
Michael Deem
Vertex-CRISPR’s Casgevy Gets Positive EMA Panel Opinion, Approval Decision in Q1 2024
Michael Deem
Boehringer Ingelheim Targets Stroma-Rich Cancers in Potential $509M AI Deal
Michael Deem
Novavax Soars on $1.4B Deal With Sanofi for COVID Vaccine
Michael Deem
Advertisement
The 7 Highest Yielding ‘Strong Buy’ Dividend Kings You Can Buy and Hold Forever
STOCK MARKET
Ipsen Inks Potential $900M Deal with Sutro for Global Rights to Preclinical ADC
Michael Deem
DeepLabCut: the motion-tracking tool that went viral
Michael Deem
Kyowa Kirin Pays $100M Upfront to BridgeBio for Skeletal Dysplasias Drug in Japan
Michael Deem
Meet ‘goldene’: this gilded cousin of graphene is also one atom thick
Michael Deem
Roche Signs Potential $1B ADC Cancer Deal with China’s MediLink
Michael Deem
This methane-sniffing satellite will leave climate polluters nowhere to hide
Michael Deem
Advertisement
Advertisement
Advertisement
نوفارتس توافق على إتاحة حقوق تصنيع دواء للسرطان لعدد من الدول لأول مرة
Cancer السرطان
